The use of biomaterials, such as hydrogels, as neural cell delivery devices is becoming more common in areas of research such as stroke, traumatic brain injury, and spinal cord injury. When reviewing the available research there is some ambiguity in the type of materials used and results are often at odds. This review aims to provide the neuroscience community who may not be familiar with fundamental concepts of hydrogel construction, with basic information that would pertain to neural tissue applications, and to describe the use of hydrogels as cell and drug delivery devices. We will illustrate some of the many tunable properties of hydrogels and the importance of these properties in obtaining reliable and consistent results. It is our hope that this review promotes creative ideas for ways that hydrogels could be adapted and employed for the treatment of a broad range of neurological disorders.
brain injury to Alzheimer's and Parkinson's diseases, the causes and manifestations of these disorders vary greatly, as do the impacts and outcomes. Likewise, treatments for these disorders are numerous and diverse; however, very few result in complete recovery and many diseases have limited treatment options and no cure.
One of the reasons for the lack of effective therapies for neurological disorders is the limited regenerative abilities of the central nervous system (Gurgo et al., 2002; Case and Tessier-Lavigne, 2005) . For example, in individuals who have suffered a stroke, there is a sustained loss of functional tissue and thus treatments are often limited to rehabilitation of lost functions, such as speech 0168-0102/$ -see front matter © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved. doi:10.1016/j.neures.2011.12.005
